lisinopril and hydrochlorothiazide (70518-0174)

Drug Facts

Product Profile

Brand Name lisinopril and hydrochlorothiazide

Generic Name lisinopril and hydrochlorothiazide

Labeler remedyrepack inc.

Dosage Form TABLET

Routes

ORAL

Active Ingredients

hydrochlorothiazide 25 mg/1, lisinopril 20 mg/1

Manufacturer

REMEDYREPACK INC.

Identifiers & Regulatory

Product NDC 70518-0174

Product ID 70518-0174_47e3f082-89ce-b50f-e063-6294a90ad1a6

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA077912

Listing Expiration 2027-12-31

Marketing Start 2017-01-23

Pharmacologic Class

Established (EPC)

thiazide diuretic [epc]

Chemical Structure

thiazides [cs]

Physiologic Effect

increased diuresis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 705180174

Hyphenated Format 70518-0174

Supplemental Identifiers

RxCUI

197887

UNII

0J48LPH2TH E7199S1YWR

NUI

N0000175359 N0000175419 M0471776

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lisinopril and hydrochlorothiazide (source: ndc)

Generic Name lisinopril and hydrochlorothiazide (source: ndc)

Application Number ANDA077912 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

25 mg/1
20 mg/1

source: ndc

Packaging

30 TABLET in 1 BOTTLE, PLASTIC (70518-0174-0)
90 TABLET in 1 BOTTLE, PLASTIC (70518-0174-1)
100 TABLET in 1 BOTTLE, PLASTIC (70518-0174-2)
30 TABLET in 1 BLISTER PACK (70518-0174-3)

source: ndc

Packages (4)

70518-0174-0 30 TABLET in 1 BOTTLE, PLASTIC (70518-0174-0) 70518-0174-1 90 TABLET in 1 BOTTLE, PLASTIC (70518-0174-1) 70518-0174-2 100 TABLET in 1 BOTTLE, PLASTIC (70518-0174-2) 70518-0174-3 30 TABLET in 1 BLISTER PACK (70518-0174-3)

Ingredients (2)

hydrochlorothiazide (25 mg/1) lisinopril (20 mg/1)

Linked Drug Pages (1)

Lisinopril and Hydrochlorothiazide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "47e3f082-89ce-b50f-e063-6294a90ad1a6", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "unii": ["0J48LPH2TH", "E7199S1YWR"], "rxcui": ["197887"], "spl_set_id": ["408e797a-2cf3-4ee6-9f9b-179a8cf3d799"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (70518-0174-0)", "package_ndc": "70518-0174-0", "marketing_start_date": "20170123"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE, PLASTIC (70518-0174-1)", "package_ndc": "70518-0174-1", "marketing_start_date": "20170202"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE, PLASTIC (70518-0174-2)", "package_ndc": "70518-0174-2", "marketing_start_date": "20170504"}, {"sample": false, "description": "30 TABLET in 1 BLISTER PACK (70518-0174-3)", "package_ndc": "70518-0174-3", "marketing_start_date": "20180306"}], "brand_name": "Lisinopril and Hydrochlorothiazide", "product_id": "70518-0174_47e3f082-89ce-b50f-e063-6294a90ad1a6", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "70518-0174", "generic_name": "Lisinopril and Hydrochlorothiazide", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lisinopril and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "25 mg/1"}, {"name": "LISINOPRIL", "strength": "20 mg/1"}], "application_number": "ANDA077912", "marketing_category": "ANDA", "marketing_start_date": "20170123", "listing_expiration_date": "20271231"}